SAN DIEGO, Calif. – Pleno Inc., a multi-omic instrument platform company revolutionizing biological target detection for clinical testing and biomedical research, announced the close of $40 million in Series A financing led by Deerfield Management Company with participation by Foresite Capital. Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and […]
Novel name reflects expansion of capabilities and solutions SAN DIEGO — Codex DNA, Inc. (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, today announced a plan to change its Company name to Telesis Bio. “Our innovative and pioneering spirit, and the versatility and power of our technologies, have enabled us to expand […]
Larger site will be future home of the Organoid Innovation Center – Salzburg, a collaborative space for advancing automated cell line development, organoid development, and screening solutions to improve drug discovery SAN JOSE, Calif., and SALZBURG, Austria – At a ribbon-cutting ceremony today, Molecular Devices, LLC., a leading provider of high-performance life science solutions, celebrated the completed […]
Company partners with leading distributors in the Gulf region and Israel as well as expands Asia Pacific coverage to Japan for sales, service and support of SYNTAX System instruments and kits SOUTH SAN FRANCISCO, Calif. & PARIS — DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has signed distribution […]
Aims to improve efficiency of pharma pipelines by leveraging industry-leading ability to identify genetic variants that contribute to human disease SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a strategic research collaboration with AstraZeneca, a global, science-led biopharmaceutical company, to accelerate drug target discovery by […]
SEATTLE–TwinStrand Biosciences, Inc. (TwinStrand), the pioneer in Duplex Sequencing technology, which delivers clearer insights to researchers and clinicians in applications ranging from residual cancer detection to genetic toxicology, today announced that the company has implemented a reorganization designed to sustain growth through a focus on key commercial initiatives. As part of this effort, TwinStrand has […]
100,000 square foot facility to support company plans for growth in clinical laboratory services, drug development services and product innovations Launch event to feature updates on Enzo plans for business growth and perspectives on prospects for the Long Island business community from community leaders including Senator John Brooks and Assemblyman Steve Stern New York, NY […]
The microfluidics-based system accommodates scalable throughputs to address specific and evolving project needsSOUTH SAN FRANCISCO, Calif. — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced the launch of the X9™ Real-Time PCR System, an innovative high-capacity genomics instrument offering superior efficiency. X9 enables […]
Enhanced NGS portfolio includes Interpret Software updates and enables rapid and confident variant detection even in difficult-to-sequence regions Oxford, UK – OGT, A Sysmex Group Company, announces the recent launch of several new solutions to support its growing NGS portfolio. These include the SureSeq™ Myeloid Plus panel, which has been designed to detect aberrations in genes […]
Novel RNA Seq-based technology offers unbiased profiling of all seven human TCR and BCR variable regions from a single sample MOUNTAIN VIEW, CA—Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor (AIR) TCR and BCR kits, a family of multiplex-PCR, NGS-based assays that enable profiling of up to all seven T-cell receptor […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
